Safeguard Scientifics Net Income Growth & History (SFES)
Safeguard Scientifics's net income was −$9.8M for fiscal 2023.
View full Safeguard Scientifics company overviewSafeguard Scientifics annual net income history
| Fiscal year | Period ended | Net income | Change | Growth |
|---|---|---|---|---|
| 2023 | 2023-12-31 | −$9.8M | $4.4M | — |
| 2022 | 2022-12-31 | −$14.3M | −$41.3M | — |
| 2021 | 2021-12-31 | $27.0M | $64.6M | — |
| 2020 | 2020-12-31 | −$37.6M | −$92.2M | — |
| 2019 | 2019-12-31 | $54.6M | $70.2M | — |
| 2018 | 2018-12-31 | −$15.6M | $72.9M | — |
| 2017 | 2017-12-31 | −$88.6M | −$66.3M | — |
| 2016 | 2016-12-31 | −$22.3M | $37.3M | — |
| 2015 | 2015-12-31 | −$59.5M | −$54.4M | — |
| 2014 | 2014-12-31 | −$5.1M | $30.4M | — |
| 2013 | 2013-12-31 | −$35.5M | $3.8M | — |
| 2012 | 2012-12-31 | −$39.4M | −$150.0M | — |
| 2011 | 2011-12-31 | $110.6M | $84.0M | +315.64% |
| 2010 | 2010-12-31 | $26.6M | −$41.0M | −60.64% |
| 2009 | 2009-12-31 | $67.6M | — | — |
Safeguard Scientifics quarterly net income
| Fiscal quarter | Period ended | Net income | Change | YoY change |
|---|---|---|---|---|
| Q4 2023 | 2023-12-31 | −$4.4M | $459,000 | — |
| Q3 2023 | 2023-09-30 | $932,000 | $4.1M | — |
| Q2 2023 | 2023-06-30 | −$2.9M | −$3.3M | — |
| Q1 2023 | 2023-03-31 | −$3.5M | $3.2M | — |
| Q4 2022 | 2022-12-31 | −$4.9M | $3.8M | — |
| Q3 2022 | 2022-09-30 | −$3.2M | −$21.5M | — |
| Q2 2022 | 2022-06-30 | $483,000 | $803,000 | — |
| Q1 2022 | 2022-03-31 | −$6.7M | −$24.3M | — |
| Q4 2021 | 2021-12-31 | −$8.6M | −$1.3M | — |
| Q3 2021 | 2021-09-30 | $18.3M | $22.7M | — |
| Q2 2021 | 2021-06-30 | −$320,000 | $9.6M | — |
| Q1 2021 | 2021-03-31 | $17.6M | $33.6M | — |
| Q4 2020 | 2020-12-31 | −$7.4M | −$6.7M | — |
| Q3 2020 | 2020-09-30 | −$4.3M | −$1.8M | — |
| Q2 2020 | 2020-06-30 | −$9.9M | −$46.0M | — |
| Q1 2020 | 2020-03-31 | −$16.0M | −$37.7M | — |
| Q4 2019 | 2019-12-31 | −$698,000 | $15.9M | — |
| Q3 2019 | 2019-09-30 | −$2.5M | −$34.6M | — |
| Q2 2019 | 2019-06-30 | $36.1M | $61.0M | — |
| Q1 2019 | 2019-03-31 | $21.7M | $27.8M | — |
| Q4 2018 | 2018-12-31 | −$16.6M | $2.1M | — |
| Q3 2018 | 2018-09-30 | $32.1M | $50.7M | — |
| Q2 2018 | 2018-06-30 | −$24.9M | $4.2M | — |
| Q1 2018 | 2018-03-31 | −$6.2M | $15.9M | — |
| Q4 2017 | 2017-12-31 | −$18.7M | $3.0M | — |
| Q3 2017 | 2017-09-30 | −$18.6M | $5.4M | — |
| Q2 2017 | 2017-06-30 | −$29.1M | −$68.1M | — |
| Q1 2017 | 2017-03-31 | −$22.1M | −$6.6M | — |
| Q4 2016 | 2016-12-31 | −$21.7M | −$7.4M | — |
| Q3 2016 | 2016-09-30 | −$24.1M | −$12.5M | — |
| Q2 2016 | 2016-06-30 | $39.0M | $58.0M | — |
| Q1 2016 | 2016-03-31 | −$15.5M | −$849,000 | — |
| Q4 2015 | 2015-12-31 | −$14.3M | $843,000 | — |
| Q3 2015 | 2015-09-30 | −$11.6M | $2.4M | — |
| Q2 2015 | 2015-06-30 | −$19.0M | −$11.7M | — |
| Q1 2015 | 2015-03-31 | −$14.6M | −$45.9M | — |
| Q4 2014 | 2014-12-31 | −$15.1M | −$39.1M | — |
| Q3 2014 | 2014-09-30 | −$14.0M | $5.4M | — |
| Q2 2014 | 2014-06-30 | −$7.3M | $20.8M | — |
| Q1 2014 | 2014-03-31 | $31.3M | $43.3M | — |
| Q4 2013 | 2013-12-31 | $24.0M | $34.8M | — |
| Q3 2013 | 2013-09-30 | −$19.4M | −$10.7M | — |
| Q2 2013 | 2013-06-30 | −$28.1M | −$18.0M | — |
| Q1 2013 | 2013-03-31 | −$11.9M | −$2.3M | — |
| Q4 2012 | 2012-12-31 | −$10.8M | $13.7M | — |
| Q3 2012 | 2012-09-30 | −$8.8M | −$31.1M | — |
| Q2 2012 | 2012-06-30 | −$10.1M | −$132.0M | — |
| Q1 2012 | 2012-03-31 | −$9.7M | −$650,000 | — |
| Q4 2011 | 2011-12-31 | −$24.5M | — | — |
| Q3 2011 | 2011-09-30 | $22.3M | $21.7M | +3646.81% |
| Q2 2011 | 2011-06-30 | $121.8M | $119.1M | +4373.56% |
| Q1 2011 | 2011-03-31 | −$9.0M | — | — |
| Q3 2010 | 2010-09-30 | $596,000 | — | — |
| Q2 2010 | 2010-06-30 | $2.7M | — | — |
Safeguard Scientifics net income trends
Over the last five fiscal years, Safeguard Scientifics's net income increased from −$15.6M to −$9.8M, a change of $5.8M. The latest reported quarter, Q4 2023, shows −$4.4M.
What net income means
Net income is a company’s bottom-line profit or loss after operating costs, interest, taxes, and other reported income and expenses. It shows how much of a company’s revenue ultimately remained as earnings, or how large its loss was, during a fiscal period.
SEC-reported net income
TickerStat standardizes consolidated net income or profit and loss reported in company SEC filings for aligned fiscal periods. It is not adjusted earnings, an analyst estimate, or company guidance. Fiscal periods can differ from calendar years, so exact period-end dates are included.
Review Safeguard Scientifics source filings ↗